Published on 1 Mar 2023 on Insider Monkey via Yahoo Finance
What Makes Rocket Pharmaceuticals (RCKT) Shares Attractive?
Baron Funds, an investment management company, released its “Baron Opportunity Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the fund declined 4.54% (Institutional Shares) compared to a 2.31% return for the Russell 3000 Growth Index and a 7.56% return for the S&P 500 Index. For the one-year period, the fund fell sharply trailing both indexes. In addition, please check the fund’s top five holdings to know its best picks in 2022.
Baron Opportunity Fund highlighted stocks like Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) in the Q4 2022 investor letter. Headquartered in Cranbury, New Jersey, Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) is a biotechnology company. On February 28, 2023, Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) stock closed at $19.21 per share. One-month return of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) was -12.64%, and its shares gained 13.74% of their value over the last 52 weeks. Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) has a market capitalization of $1.512 billion.